Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in CRISPR therapeutics
Michael Chavez, Xinyi Chen, Paul B. Finn, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 9-22
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 62
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 51
In situ targeted base editing of bacteria in the mouse gut
Andreas K. Brödel, Loïc H. Charpenay, Matthieu Galtier, et al.
Nature (2024) Vol. 632, Iss. 8026, pp. 877-884
Open Access | Times Cited: 32
Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing
Misganaw Asmamaw Mengstie, Muluken Teshome Azezew, Tadesse Asmamaw Dejenie, et al.
Biologics (2024) Vol. Volume 18, pp. 21-28
Open Access | Times Cited: 24
Interpreting non-coding disease-associated human variants using single-cell epigenomics
Kyle J. Gaulton, Sebastian Preißl, Bing Ren
Nature Reviews Genetics (2023) Vol. 24, Iss. 8, pp. 516-534
Open Access | Times Cited: 38
Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases
Tara Fiyouzi, Hector F. Pelaez-Prestel, Raquel Ruz Reyes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7797-7797
Open Access | Times Cited: 28
Redox-Responsive Phase-Separating Peptide as a Universal Delivery Vehicle for CRISPR/Cas9 Genome Editing Machinery
Yue Sun, Xiaojie Xu, Liwei Chen, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16597-16606
Closed Access | Times Cited: 24
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications
Yanjun Zhang, Lijuan Zhan, Xue Jiang, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116218-116218
Closed Access | Times Cited: 11
Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants
Heon Seok Kim, Jiyeon Kweon, Yongsub Kim
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 4, pp. 861-869
Open Access | Times Cited: 10
Prime editing: Mechanism insight and recent applications in plants
Tien Van Vu, Ngan Thi Nguyen, Jihae Kim, et al.
Plant Biotechnology Journal (2023) Vol. 22, Iss. 1, pp. 19-36
Open Access | Times Cited: 18
CRISPR-cas technology: A key approach for SARS-CoV-2 detection
Lijuan Fang, Lusen Yang, Mingyue Han, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 17
Neuronal regeneration after injury: a new perspective on gene therapy
Chih‐Wei Zeng, Chunli Zhang
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 13
Natural components as surface engineering agents for CRISPR delivery
Navid Rabiee
Environmental Research (2023) Vol. 232, pp. 116333-116333
Open Access | Times Cited: 13
Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases
Federica Esposito, Fabio Dell’Aquila, Manuel Rhiel, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101619-101619
Open Access | Times Cited: 5
Engineering Phages to Fight Multidrug-Resistant Bacteria
Huan Peng, Irene A. Chen, Udi Qimron
Chemical Reviews (2024)
Open Access | Times Cited: 5
Swine clones: potential application for animal production and animal models
Thaís Naomi Gonçalves Nesiyama, Juliano Rodrigues Sangalli, Tiago Henrique Camara De, et al.
Animal Reproduction (2025) Vol. 22, Iss. 1
Open Access
Exosome-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy
Bhavanisha Rithiga S, Rajib Dhar, Arikketh Devi
Gene (2025), pp. 149296-149296
Closed Access
Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics
Emmanuelle Cacoub, Nathalie Barreto Lefebvre, Dimitrije Milunov, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
CRISPR-Based Genetic Improvement of Aquaculture Species
Abdulkadir Bayır, Selma Saoula, Ammar Almansour, et al.
Fishes (2025) Vol. 10, Iss. 2, pp. 84-84
Open Access
Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo
Xuexiang Han, Ying Xu, Adele S. Ricciardi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
CRISPR-Cas: a game-changer in vaccine development and the fight against viral infections
Fayu Yang, Saba R. Aliyari, Zixiang Zhu, et al.
Trends in Microbiology (2025)
Closed Access
CRISPR-Cas9 Teknolojisi ile Genetik Hastalıkların Tedavisi: Yeni Bir Devrim
Sebile Azırak, Ahmet Genç
(2025) Vol. 03, pp. 29-40
Closed Access
In vitro activation of anti-cancer gene expression by delivery of CRISPR/dCas9 ribonucleoproteins to suppress glioblastoma
Mei‐Hwa Lee, James L. Thomas, Yu‐Ling Lin, et al.
International Journal of Biological Macromolecules (2025), pp. 142289-142289
Closed Access
Engineered circular guide RNAs enhance miniature CRISPR/Cas12f-based gene activation and adenine base editing
Xin Zhang, Mengrao Li, Kechen Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The potential of advanced crop breeding technologies for sustainable food security
Syed Asim Shah Bacha, Shashi Kiran, Fengjie Cui, et al.
International Journal of Biological Macromolecules (2025), pp. 143025-143025
Closed Access
Page 1 - Next Page

Scroll to top